Alnylam Pharmaceuticals, Inc. (ALNY)

297.69 +5.53 (+1.89%) USD  |  NASDAQ  |  Jun 09, 16:00
297.61 -0.08 (-0.03%) Pre-Market: 08:05
More

Alnylam Pharmaceuticals Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Ionis Pharmaceuticals, Inc. Upgrade
Incyte Corp. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Insmed, Inc. Upgrade